Blue Sky BioServices
Biotechnology ResearchMassachusetts, United States51-200 Employees
Blue Sky BioServices operates as a contract research organization in the biotechnology sector, offering R&D-driven gene-to-screen services for biotech and pharmaceutical companies ranging from startups to established leaders. Founded in 2003 to serve the Boston life sciences research hub, it is based in Worcester, Massachusetts. The company provides gene synthesis and plasmid preparation, antibody cloning, and scalable production of recombinant proteins across multiple cell systems, together with purification and rapid assays. Its assay group supports a range of screening formats in 96- and 384-well plates, enabling flexible workflow options for customers. Blue Sky emphasizes its team of experienced scientists, modern facilities, and advanced process technology as differentiators aimed at delivering high-quality work with timely turnaround and competitive pricing. In 2016, Blue Sky BioServices merged with LakePharma, with LakePharma subsequently announcing the acquisition of Blue Sky BioServices.